In Vitro Antileishmanial Activity of Nicotinamide

AUTOR(ES)

Sereno, D.

FONTE

American Society for Microbiology

RESUMO

Our study represents the first report demonstrating the antileishmanial activity of nicotinamide (NAm), a form of vitamin B3. A 5 mM concentration of NAm significantly inhibited the intracellular growth of Leishmania amastigotes and the NAD-dependent deacetylase activity carried by parasites overexpressing Leishmania major SIR2 (LmSIR2). However, the transgenic parasites were as susceptible as the wild-type parasites to NAm-induced cell growth arrest. Therefore, we conclude that NAm inhibits leishmanial growth and that overexpression of LmSIR2 does not overcome this inhibition. The mechanism of the inhibition is not defined but may include other in vivo targets. NAm may thus represent a new antileishmanial agent which could potentially be used in combination with other drugs during therapy.

Documentos Relacionados

• Semiautomated assessment of in vitro activity of potential antileishmanial drugs.
• In Vitro Assessment of Antileishmanial Activity of Natamycin and Nystatin
• In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
• Antileishmanial activity of chlorpromazine.
• Neolignans isolated from twigs of Nectandra leucantha Ness & Mart (Lauraceae) displayed in vitro antileishmanial activity